Weighing the evidence for infection as a risk factor for coronary heart disease

Current Cardiology Reports

Volumn 2, Issue 4, 2000, Pages 280-287

  O'Donnell, Christopher J ^a   Levy, Daniel ^a  

^a FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; HUMAN; MICROBIOLOGY; REVIEW; RISK FACTOR; VIRUS INFECTION;

BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CAUSALITY; CORONARY DISEASE; HUMANS; RISK FACTORS; VIRUS DISEASES;

EID: 0034222406     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0082-6     Document Type: Article

References (47)

1. American Heart Association: 2000 Heart and Stroke Statistical Update. Dallas: American Heart Association; 2000.
2. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet 1997, 350:430-436.
3. Thom DH, Wang SP, Grayston JT, et al. : Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991, 11:547-551.
4. Patel P, Mendall MA, Carrington D, et al. : Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995, 311:711-714.
5. Cook PJ, Honeybourne D, Lip GY, et al. : Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998, 29:404-410.
6. Ridker PM, Kundsin RB, Stampfer MJ, et al. : Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999, 99:1161-1164.
7. Ridker PM, Hennekens CH, Buring JE, et al. : Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999, 131:573-577.
8. Ridker PM, Hennekens CH, Stampfer MJ, Wang F: Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998, 98:2796-2799.
9. Haider AW, Wilson PWF, Larson MG, et al. : Association of H Pylori, C Pneumoniae and Cytomegalovirus Seropositivity with Cardiovascular Disease in the Framingham Heart Study [abstract]. Circulation 1999, 100:I-232.
10. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997, 96:4095-4103.
11. Muhlestein JB, Hammond EH, Carlquist JF, et al. : Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 1996, 27:1555-1561.
12. Chiu B: Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999, 138:S534-S536.
13. Maass M, Bartels C, Kruger S, et al. : Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998, 140(suppl 1):S25-S30.
14. Kol A, Sukhova GK, Lichtman AH, Libby P: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998, 98:300-307.
15. Kol A, Bourcier T, Lichtman AH, Libby P: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999, 103:571-577.
16. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999, 100:e20-e28.
17. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998, 279:1477-1482.
18. Lowe GD, Machado SG, Krol WF, et al. : White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985, 54:700-703.
19. Schlant RC, Forman S, Stamler J, Canner PL: The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation 1982, 66:401-414.
20. Lloyd-Jones DM, Camargo CA, Giugliano RP, O'Donnell CJ: Effect of leukocytosis at presentation on prognosis in patients with primary unstable angina. Am Heart J 2000, in press.
21. Kannel WB, Anderson K, Wilson PW: White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992, 267:1253-1256.
22. Ridker PM, Cushman M, Stampfer MJ, et al. : Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
23. Wilson PWF, D'Agostino RB, Levy D, et al. : Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
24. O'Donnell CJ, Larson MG, Benjamin E, et al. : Relationship of C-reactive protein to coronary and aortic calcification in the Framingham Heart Study [abstract]. Circulation 2000, 101:713-714.
25. Haider AW, Larson MG, O'Donnell CJ, et al. : The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study. Am J Med 2000, 106:279-284.
26. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R: Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 1998, 3:127-141.
27. Christen WG, Hennekens CH, Ajani UA, et al. : Periodontal disease and risks of cardiovascular disease [abstract]. Circulation 1998, 97:821.
28. Zhu J, Quyyumi AA, Norman JE, et al. : Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000, 85:140-146.
29. Ossewaarde JM, Feskens EJ, De Vries A, et al. : Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998, 120:93-99.
30. Roivainen M, Viik-Kajander M, Palosuo T, et al. : Infections, inflammation, and the risk of coronary heart disease. Circulation 2000, 101:252-257.
31. Gupta S, Leatham EW, Carrington D, et al. : Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997, 96:404-407.
32. Saikku P, Leinonen M, Tenkanen L, et al. : Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992, 116:273-278.
33. Miettinen H, Lehto S, Saikku P, et al. : Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996, 17:682-688.
34. Whincup PH, Mendall MA, Perry IJ, et al. : Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996, 75:568-572.
35. Strandberg TE, Tilvis RS, Vuoristo M, et al. : Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. Br Med J 1997, 314:1317-1318.
36. Fagerberg B, Gnarpe J, Gnarpe H, et al. : Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999, 30:299-305.
37. Epstein SE, Zhu J: Lack of association of infectious agents with risk of future myocardial infarction and stroke: definitive evidence disproving the infection/coronary artery disease hypothesis [editorial]? Circulation 1999, 100:1366-1368.
38. Meier CR, Derby LE, Jick SS, et al. : Antibiotics and risk of subsequent first-time acute myocardial infarction . JAMA 1999, 281:427-431.
39. Anderson JL, Muhlestein JB, Carlquist J, et al. : Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: the Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation 1999, 99:1540-1547.
40. Gurfinkel E, Bozovich G, Daroca A, et al. : Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997, 350:404-407.
41. Gurfinkel E, Bozovich G, Beck E, et al. : Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J 1999, 20:121-127.
42. Grayston JT, Jackson LA, Kennedy WJ, Kronmal RA: Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues. Am Heart J 1999, 138:S545-S549.
43. Dunne M: WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics. Am Heart J 1999, 138:S542-S544.
44. O'Donnell CJ, Kannel WB: Cardiovascular risks of hypertension: lessons from observational studies. J Hypertens Suppl 1998, 16(Suppl 6):S3-S7.
45. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
46. Nieto FJ, Folsom AR, Sorlie PD, et al. : Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999, 150:149-156.
47. Folsom AR, Nieto FJ, Sorlie PD, et al. : Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1998, 98:845-850.